All changes for the tissue kidney (65)
Identifier
Name
Type
Tissues
Organism
Gene
Data
Actions
DAA886
Renal arteriosclerosis
Pathological
renal vasculature
Human
—
—
DAA2020
Reduction in renal function
Physiological
kidney
Human
—
—
DAA639
Kidney diseases
Pathological
kidney
Human
—
SeriesMorbidity
DAA880
Kidney mass gradually lost
Physiological
kidney
Human
—
—
DAA277
tyrosinase-related protein 1
Molecular
kidney
Human
TYRP1
21.0% Decrease Gene Expression Level
DAA286
StAR-related lipid transfer (START) domain containing 8
Molecular
kidney
Human
STARD8
14.0% Decrease Gene Expression Level
DAA268
solute carrier family 12 (sodium/chloride transporters), member 3
Molecular
kidney
Human
SLC12A3
16.0% Decrease Gene Expression Level
DAA282
serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 5
Molecular
kidney
Human
SERPINA5
11.0% Decrease Gene Expression Level
DAA278
Ras-related GTP binding D
Molecular
kidney
Human
RRAGD
14.0% Decrease Gene Expression Level
DAA276
Rh family, C glycoprotein
Molecular
kidney
Human
RHCG
16.0% Decrease Gene Expression Level
DAA264
paraoxonase 3
Molecular
kidney
Human
PON3
13.0% Decrease Gene Expression Level
DAA279
nicotinamide N-methyltransferase
Molecular
kidney
Human
NNMT
40.0% Increase Gene Expression Level
DAA266
matrix metallopeptidase 7 (matrilysin, uterine)
Molecular
kidney
Human
MMP7
23.0% Increase Gene Expression Level
DAA290
lysozyme (renal amyloidosis)
Molecular
kidney
Human
LYZ
57.0% Increase Gene Expression Level
DAA283
lactotransferrin
Molecular
kidney
Human
LTF
115.0% Increase Gene Expression Level
DAA270
lipoprotein lipase
Molecular
kidney
Human
LPL
17.0% Decrease Gene Expression Level
DAA257
kininogen 1
Molecular
kidney
Human
KNG1
17.0% Decrease Gene Expression Level
DAA262
kelch-like 3 (Drosophila)
Molecular
kidney
Human
KLHL3
14.0% Decrease Gene Expression Level
DAA284
immunoglobulin lambda variable 4-3
Molecular
kidney
Human
IGLV4-3
41.0% Increase Gene Expression Level
DAA274
immunoglobulin lambda variable 3-25
Molecular
kidney
Human
IGLV3-25
46.0% Increase Gene Expression Level
DAA285
immunoglobulin kappa variable 1-5
Molecular
kidney
Human
IGKV1-5
35.0% Increase Gene Expression Level
DAA259
immunoglobulin J polypeptide, linker protein for immunoglobulin alpha and mu polypeptides
Molecular
kidney
Human
IGJ
60.0% Increase Gene Expression Level
DAA280
FXYD domain containing ion transport regulator 2
Molecular
kidney
Human
FXYD2
5.0% Decrease Gene Expression Level
DAA271
epidermal growth factor (beta-urogastrone)
Molecular
kidney
Human
EGF
25.0% Decrease Gene Expression Level
DAA258
EF-hand domain family, member D1
Molecular
kidney
Human
EFHD1
9.0% Decrease Gene Expression Level
Identifier | Name | Type | Tissues | Organism | Gene | Data | Actions |
---|---|---|---|---|---|---|---|
DAA886 | Renal arteriosclerosis | Pathological | renal vasculature | Human | — | — | |
DAA2020 | Reduction in renal function | Physiological | kidney | Human | — | — | |
DAA639 | Kidney diseases | Pathological | kidney | Human | — | SeriesMorbidity | |
DAA880 | Kidney mass gradually lost | Physiological | kidney | Human | — | — | |
DAA277 | tyrosinase-related protein 1 | Molecular | kidney | Human | TYRP1 | 21.0% Decrease Gene Expression Level | |
DAA286 | StAR-related lipid transfer (START) domain containing 8 | Molecular | kidney | Human | STARD8 | 14.0% Decrease Gene Expression Level | |
DAA268 | solute carrier family 12 (sodium/chloride transporters), member 3 | Molecular | kidney | Human | SLC12A3 | 16.0% Decrease Gene Expression Level | |
DAA282 | serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 5 | Molecular | kidney | Human | SERPINA5 | 11.0% Decrease Gene Expression Level | |
DAA278 | Ras-related GTP binding D | Molecular | kidney | Human | RRAGD | 14.0% Decrease Gene Expression Level | |
DAA276 | Rh family, C glycoprotein | Molecular | kidney | Human | RHCG | 16.0% Decrease Gene Expression Level | |
DAA264 | paraoxonase 3 | Molecular | kidney | Human | PON3 | 13.0% Decrease Gene Expression Level | |
DAA279 | nicotinamide N-methyltransferase | Molecular | kidney | Human | NNMT | 40.0% Increase Gene Expression Level | |
DAA266 | matrix metallopeptidase 7 (matrilysin, uterine) | Molecular | kidney | Human | MMP7 | 23.0% Increase Gene Expression Level | |
DAA290 | lysozyme (renal amyloidosis) | Molecular | kidney | Human | LYZ | 57.0% Increase Gene Expression Level | |
DAA283 | lactotransferrin | Molecular | kidney | Human | LTF | 115.0% Increase Gene Expression Level | |
DAA270 | lipoprotein lipase | Molecular | kidney | Human | LPL | 17.0% Decrease Gene Expression Level | |
DAA257 | kininogen 1 | Molecular | kidney | Human | KNG1 | 17.0% Decrease Gene Expression Level | |
DAA262 | kelch-like 3 (Drosophila) | Molecular | kidney | Human | KLHL3 | 14.0% Decrease Gene Expression Level | |
DAA284 | immunoglobulin lambda variable 4-3 | Molecular | kidney | Human | IGLV4-3 | 41.0% Increase Gene Expression Level | |
DAA274 | immunoglobulin lambda variable 3-25 | Molecular | kidney | Human | IGLV3-25 | 46.0% Increase Gene Expression Level | |
DAA285 | immunoglobulin kappa variable 1-5 | Molecular | kidney | Human | IGKV1-5 | 35.0% Increase Gene Expression Level | |
DAA259 | immunoglobulin J polypeptide, linker protein for immunoglobulin alpha and mu polypeptides | Molecular | kidney | Human | IGJ | 60.0% Increase Gene Expression Level | |
DAA280 | FXYD domain containing ion transport regulator 2 | Molecular | kidney | Human | FXYD2 | 5.0% Decrease Gene Expression Level | |
DAA271 | epidermal growth factor (beta-urogastrone) | Molecular | kidney | Human | EGF | 25.0% Decrease Gene Expression Level | |
DAA258 | EF-hand domain family, member D1 | Molecular | kidney | Human | EFHD1 | 9.0% Decrease Gene Expression Level |